Octreotide for treating chylothorax after cardiac surgery.
Chylothorax is a rare but serious complication of cardiac surgery, with a poor prognosis unless treated properly. We report the case of 66-year-old woman who developed chylothorax after coronary artery bypass grafting. The chylothorax was successfully treated in 8 days by means of subcutaneous octreotide administration and a diet that contained medium-chain triglycerides. Octreotide, a long-acting somatostatin analog, is an effective and safe agent for the treatment of postoperative chylothorax and may reduce the need for reoperation.
Kilic
Dalokay
D
Department of Thoracic and Cardiovascular Surgery, Baskent University Faculty of Medicine, Adana Teaching and Medical Research Center, Adana, Turkey. dalokay7@yahoo.com
Sahin
Ekber
E
Gulcan
Oner
O
Bolat
Bulent
B
Turkoz
Riza
R
Hatipoglu
Ahmet
A
D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D002916:Chylothorax / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D003327:Coronary Disease / Q000601:surgery; D004322:Drainage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015282:Octreotide / Q000627:therapeutic use*; D011183:Postoperative Complications
D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide